Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Chemother ; 25(6): 413-422, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30905628

ABSTRACT

The Japanese Surveillance Committee conducted a second nationwide surveillance of antimicrobial susceptibility patterns of uropathogens responsible for acute uncomplicated cystitis (AUC) in premenopausal patients aged 16-40 years old at 31 hospitals throughout Japan from March 2015 to February 2016. In this study, the susceptibility of causative bacteria (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus) for various antimicrobial agents was investigated by isolation and culturing of organisms obtained from urine samples. In total, 324 strains were isolated from 361 patients, including E. coli (n = 220, 67.9%), S. saprophyticus (n = 36, 11.1%), and K. pneumoniae (n = 7, 2.2%). The minimum inhibitory concentrations (MICs) of 20 antibacterial agents for these strains were determined according to the Clinical and Laboratory Standards Institute (CLSI) manual. At least 93% of the E. coli isolates showed susceptibility to fluoroquinolones and cephalosporins, whereas 100% of the S. saprophyticus isolates showed susceptibility to fluoroquinolones and aminoglycosides. The proportions of fluoroquinolone-resistant and extended-spectrum ß-lactamase (ESBL)-producing E. coli strains were 6.4% (13/220) and 4.1% (9/220), respectively. The antimicrobial susceptibility of K. pneumoniae was retained during the surveillance period, while no multidrug-resistant strains were identified. In summary, antimicrobial susceptibility results of our second nationwide surveillance did not differ significantly from those of the first surveillance. Especially the numbers of fluoroquinolone-resistant and ESBL-producing E. coli strains were not increased in premenopausal patients with AUC in Japan.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cystitis/drug therapy , Drug Resistance, Multiple, Bacterial , Escherichia coli/drug effects , Klebsiella pneumoniae/drug effects , Staphylococcus saprophyticus/drug effects , Adolescent , Adult , Anti-Bacterial Agents/therapeutic use , Cystitis/epidemiology , Cystitis/microbiology , Epidemiological Monitoring , Escherichia coli/isolation & purification , Escherichia coli/metabolism , Female , Humans , Japan , Klebsiella pneumoniae/isolation & purification , Klebsiella pneumoniae/metabolism , Male , Microbial Sensitivity Tests , Middle Aged , Staphylococcus saprophyticus/isolation & purification , Staphylococcus saprophyticus/metabolism , Young Adult , beta-Lactamases/metabolism
2.
J Infect Chemother ; 21(5): 340-5, 2015 May.
Article in English | MEDLINE | ID: mdl-25727286

ABSTRACT

Worldwide, the most important concern in the treatment of sexually transmitted infections is the increase in antimicrobial resistant Neisseria gonorrhoeae strains including resistance to cephalosporins, penicillins, fluoroquinolones or macrolides. To investigate the trends of antimicrobial susceptibility among N. gonorrhoeae strains isolated from male patients with urethritis, a Japanese surveillance committee conducted the second nationwide surveillance study. Urethral discharge was collected from male patients with urethritis at 26 medical facilities from March 2012 to January 2013. Of the 151 specimens, 103 N. gonorrhoeae strains were tested for susceptibility to 20 antimicrobial agents. None of the strains was resistant to ceftriaxone, but the minimum inhibitory concentration (MIC) 90% of ceftriaxone increased to 0.125 µg/ml, and 11 (10.7%) strains were considered less susceptible with an MIC of 0.125 µg/ml. There were 11 strains resistant to cefixime, and the MICs of these strains were 0.5 µg/ml. The distributions of the MICs of fluoroquinolones, such as ciprofloxacin, levofloxacin and tosufloxacin, were bimodal. Sitafloxacin, a fluoroquinolone, showed strong activity against all strains, including strains resistant to other three fluoroquinolones, such as ciprofloxacin, levofloxacin and tosufloxacin. The azithromycin MICs in 2 strains were 1 µg/ml.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Neisseria gonorrhoeae/drug effects , Population Surveillance , Urethritis/microbiology , Adolescent , Adult , Aged , Azithromycin/pharmacology , Cefixime/pharmacology , Ceftriaxone/pharmacology , Fluoroquinolones/pharmacology , Humans , Japan , Male , Microbial Sensitivity Tests , Middle Aged , Penicillins/pharmacology , Young Adult
3.
Anticancer Res ; 29(2): 677-80, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19331221

ABSTRACT

Primary liposarcoma of the spermatic cord (LSC) is a rare neoplasm; there are fewer than 100 cases reported in the English literature worldwide. A seventy-one year-old man, who had undergone radical retropubic prostatectomy (RRP) for localized prostate cancer in November 2004, noticed the enlargement of a mass in the left scrotum. Subsequently he underwent a biopsy of the lesion, which documented suspicion of leiomyosarcoma of the spermatic cord. Left radical orchiectomy was performed extending to the resection margin. The pathological examination showed a dedifferentiated liposarcoma of the left spermatic cord. To the best of our knowledge, this is the first report of LSC after RRP for prostate cancer in the English literature.


Subject(s)
Genital Neoplasms, Male/diagnosis , Liposarcoma/diagnosis , Prostatic Neoplasms/surgery , Spermatic Cord/pathology , Aged , Genital Neoplasms, Male/surgery , Humans , Liposarcoma/surgery , Male , Orchiectomy , Prostatectomy , Spermatic Cord/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...